State Street’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-800,108
Closed -$23.4M 3774
2017
Q3
$23.4M Sell
800,108
-8,723
-1% -$244K ﹤0.01% 1920
2017
Q2
$21.2M Buy
808,831
+12,607
+2% +$310K ﹤0.01% 1942
2017
Q1
$18.6M Buy
796,224
+40,079
+5% +$989K ﹤0.01% 1998
2016
Q4
$19M Buy
756,145
+56,414
+8% +$1.42M ﹤0.01% 1936
2016
Q3
$19.6M Sell
699,731
-99,947
-12% -$2.56M ﹤0.01% 1782
2016
Q2
$19.7M Sell
799,678
-87,994
-10% -$2.18M ﹤0.01% 1765
2016
Q1
$19.6M Buy
887,672
+164,811
+23% +$4.39M ﹤0.01% 1733
2015
Q4
$25.3M Sell
722,861
-2,419
-0.3% -$75.8K ﹤0.01% 1545
2015
Q3
$20.6M Sell
725,280
-12,124
-2% -$407K ﹤0.01% 1718
2015
Q2
$24.6M Buy
737,404
+81,563
+12% +$2.5M ﹤0.01% 1726
2015
Q1
$18.5M Buy
655,841
+41,907
+7% +$1.04M ﹤0.01% 1900
2014
Q4
$12.7M Buy
613,934
+15,370
+3% +$365K ﹤0.01% 2087
2014
Q3
$14.6M Sell
598,564
-7,028
-1% -$186K ﹤0.01% 1946
2014
Q2
$17.3M Sell
605,592
-2,427
-0.4% -$67.5K ﹤0.01% 1903
2014
Q1
$17M Buy
608,019
+7,437
+1% +$183K ﹤0.01% 1899
2013
Q4
$12.9M Sell
600,582
-41,450
-6% -$753K ﹤0.01% 2040
2013
Q3
$8.53M Sell
642,032
-15,032
-2% -$203K ﹤0.01% 2214
2013
Q2
$9.11M Buy
+657,064
New +$9.31M ﹤0.01% 2103

State Street's PMC Position: Q4 2017 in Review

State Street sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 800,108 shares — an estimated $23.4M sold.

State Street first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $25.3M in Q4 2015. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

  • State Street reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
  • State Street sold 800,108 PharMerica Corporation shares in Q4 2017, an estimated $23.4M.
  • State Street first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
  • State Street's PharMerica Corporation position peaked at $25.3M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on State Street's 13F filing for Q4 2017, filed 14 Feb 2018.